Loading...
Health and Economic Outcomes of Introducing the New MenB Vaccine (Bexsero) into the Italian Routine Infant Immunisation Programme
INTRODUCTION: In January 2013 a novel type of multicomponent protein-based vaccine against group B meningococcal disease was licensed by the European Medicines Agency. With the widespread use of the meningococcal serogroup C conjugate vaccines, serogroup B remains now the major cause of bacterial me...
Na minha lista:
| Udgivet i: | PLoS One |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Public Library of Science
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4395261/ https://ncbi.nlm.nih.gov/pubmed/25874805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0123383 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|